Skip to main content
    F

    Fate Therapeutics Inc (FATE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.02
    -0.12 (-10.53%)

    Market Cap: $138.71M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Fate Therapeutics Inc (FATE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Fate Therapeutics (FATE) has a latest price of $1.02 on Nov 17, 2026, 68.4% below its 52-week high of $3.23. Its price rose 5.8% over the past 12 months. The month-end price fell 1.0% over the 10 years through Oct 2026, a compound annual decline of 0.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $90.93 in Dec 2020 and its lowest $0.79 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart FATE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FATE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 61.5%, and over 6 months it fell 46.0%. The month-end price rose 14.9% over the 3 years through Oct 2026, a compound annual rate of 4.7%.

    PeriodChange
    1 month-45.2%
    3 months-61.5%
    6 months-46.0%
    12 months+5.8%
    12 months, with dividends+5.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+14.9%+4.7%
    5 years-96.1%-47.8%
    10 years-1.0%-0.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 364.6%, and its weakest was 2022, when it fell 82.8%.

    YearCloseChange
    2026 through Oct 2026$2.08+111.7%
    2025$0.98-40.4%
    2024$1.65-55.9%
    2023$3.74-62.9%
    2022$10.09-82.8%
    2021$58.51-35.7%
    2020$90.93+364.6%
    2019$19.57+52.5%
    2018$12.83+110.0%
    2017$6.11+143.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 51.4% below its 50-day average of $2.10 and 48.6% below its 200-day average of $1.98.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.02
    52-week high$3.23-68.4%
    52-week low$0.95+7.3%
    50-day average$2.10-51.4%
    200-day average$1.98-48.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 91.9%.

    MeasureValue
    1-year beta2.31
    Largest fall, 1 year-67.2%
    Largest fall, 3 years-91.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About FATE

    What is FATE's 1-year price change?

    Fate Therapeutics's price rose 5.8% over the past 12 months. With dividends included, the 12-month total return was 5.8%.

    What is FATE's 5-year price change?

    Fate Therapeutics's month-end price fell 96.1% over the 5 years through Oct 2026, a compound annual decline of 47.8%. These figures leave out dividends.

    What is FATE's 52-week high and low?

    Fate Therapeutics's 52-week high is $3.23 and its 52-week low is $0.95. Its latest price of $1.02 on Nov 17, 2026 is 68.4% below the high.

    What is FATE's beta?

    Fate Therapeutics's 1-year beta against the S&P 500 is 2.31, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 67.2%.

    Is the FATE chart free?

    Yes. Advanced Charting for FATE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.